Clinical Trials Logo
  1. Home
  2. Spinal Cord Injury, Acute
  3. NCT05693181

Cord Blood Cells in Patients With Acute SCI — SUBSCI II  

Spinal Cord Injury, Acute Clinical Trial

Official title:
Systemic Administration of Allogenic Mononuclear Cord Blood Cells in Patients With Acute Severe Contusion Spinal Cord Injury: Safety and Efficiency Evaluation, Stages I/II

Clinical Trial Summary

This is a prospective, single-blinded, single-center, randomized, comparative, interventional clinical study of systemic mononuclear multiple allogenic cord blood cells administration safety and efficiency in patients having acute severe contusion spinal cord injury (ASIA A/B), phase I/II

Clinical Trial Description

Phase I/II of the SUBSCI II (Systemic Umbilical Cord Blood Administration in Patients with Acute Severe Contusion Spinal Cord Injury II) study is focused on safety and primary efficacy of multiple systemic infusions of allogeneic unrelated human umbilical cord blood mononuclear cells in patients with severe acute spinal cord contusion having severe neurologic deficit (ASIA A/B). In a previous clinical study (SUBSCI I/IIa) complete safety and significant efficiency of systemic administration of human umbilical cord blood cells (HUCBCs) was demonstrated. Current study is established to confirm and verify the obtained results in a larger group of patients. SUBSCI II study includes 80 patients with acute severe contusion spinal cord injury (SCI) and American Spinal Injury Association (ASIA) level A/B deficit divided into 2 groups (experimental and control groups, 40 patients in each). Patients will be treated with 4 infusions of group-matched and rhesus-matched cord blood samples following primary decompressive and stabilizing surgery within 7 days after SCI. All patients will be followed up for 12 months after SCI. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT05693181
Study type Interventional
Source Sklifosovsky Institute of Emergency Care
Contact
Status Recruiting
Phase Phase 1/Phase 2
Start date December 5, 2022
Completion date August 30, 2025
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT04812431 - Safety and Exploratory Efficacy of Transplantation Therapy Using PSA-NCAM(+) NPC in AIS-A Level of Sub-acute SCI Phase 1/Phase 2
Enrolling by invitation NCT05047120 - Hypnotic Cognitive Therapy Reduce Acute & Chronic SCI Pain in Inpatient Rehabilitation N/A
Completed NCT03707704 - Quality Control of a Strengthening Protocol in Subjects With Spinal Cord Injury
Completed NCT03935321 - NISCI - Nogo Inhibition in Spinal Cord Injury Phase 2
Active, not recruiting NCT03505463 - The Neuroinflammatory Response and Biomarkers in Acute Traumatic Spinal Cord Injury
Recruiting NCT03965299 - Transcutaneous Tibial Nerve Stimulation in Acute Spinal Cord Injury N/A
Recruiting NCT04064385 - Functional Electrical Stimulation Cycling in SCI N/A
Completed NCT01889940 - Effectiveness of Psycho-emotional Support in Acute Spinal Cord Injury. ESPELMA Project N/A
Terminated NCT03083366 - Sacral Nerve Stimulation in Improving Bladder Function After Acute Traumatic Spinal Cord Injury N/A
Recruiting NCT02991690 - Systemic Hypothermia in Acute Cervical Spinal Cord Injury N/A
Completed NCT03661294 - Investigating the Energy Expenditure of Acute Spinal Cord Injured Patients N/A